Serina Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Serina Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Serina Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 82.1 %, a 855% increase year-over-year.
  • Serina Therapeutics, Inc. annual Return On Equity for 2023 was 45.1 %, a 16.2% decline from 2022.
  • Serina Therapeutics, Inc. annual Return On Equity for 2022 was 53.8 %, a 43.8% decline from 2021.
  • Serina Therapeutics, Inc. annual Return On Equity for 2021 was 95.7 %, a 74.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 45.1 -8.72 -16.2% Jan 1, 2023 Dec 31, 2023
2022 53.8 -41.9 -43.8% Jan 1, 2022 Dec 31, 2022
2021 95.7 -278 -74.4% Jan 1, 2021 Dec 31, 2021
2020 373 +568 Jan 1, 2020 Dec 31, 2020
2019 -195 -120 -160% Jan 1, 2019 Dec 31, 2019
2018 -74.8 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.